Pacira BioSciences
PCRX
PCRX
272 hedge funds and large institutions have $1.84B invested in Pacira BioSciences in 2022 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 95 increasing their positions, 93 reducing their positions, and 42 closing their positions.
Holders
272
Holders Change
–
Holders Change %
0%
% of All Funds
4.39%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
46
Increased
95
Reduced
93
Closed
42
Calls
$903K
Puts
$3.58M
Net Calls
-$2.67M
Net Calls Change
-$189K
Top Buyers
1 |
1
Millennium Management
New York
|
$44.5M |
2 |
AC
2
Armistice Capital
New York
|
$73.1M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$11.1M |
4 |
4
Invesco
Atlanta,
Georgia
|
$52.5M |
5 |
CSS
5
Cubist Systematic Strategies
Stamford,
Connecticut
|
$7.13M |